Lacryvisc

Carbomer 974p, the active ingredient in Lacryvisc, is an excipient presented as a polymer in ophthalmic solutions for ocular use. It enhances the viscosity of eye drops to improve drug residence time on the ocular surface.

GNH USA supplies Lacryvisc as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Lacryvisc is a viscosity‑enhancing excipient used in ophthalmic formulations to improve drug retention on the eye surface.

- Dry Eye Syndrome: improves tear film stability and prolongs ocular surface hydration. - Post‑surgical eye drops: prolongs drug contact time, supporting healing after ocular surgery. - Ocular inflammation treatments: enhances ocular drug retention, aiding anti‑inflammatory efficacy.

Lacryvisc may cause ocular reactions, most of which are mild and transient.

Common Side Effects: - Transient blurred vision: temporary visual disturbance after instillation. - Mild ocular irritation: slight stinging or burning sensation. - Temporary tearing: increased tear production that resolves quickly.

Serious or Rare Side Effects: - Allergic conjunctivitis: redness, swelling, and itching requiring discontinuation. - Corneal edema: swelling of the cornea, a rare but serious event. - Severe ocular inflammation: intense redness and pain indicating an adverse reaction.

When using Lacryvisc, consider the following precautions to ensure safety and product integrity.

- Assess patient history: verify no known hypersensitivity to carbomer polymers. - Avoid use on compromised corneal epithelium: may exacerbate irritation. - Monitor for ocular discomfort: discontinue if severe irritation occurs. - Do not combine with incompatible preservatives: may affect formulation stability. - Store at ambient temperature: keep in the original container, protect from moisture and light.

Lacryvisc can interact with certain ophthalmic components, affecting formulation stability or ocular tolerance.

Major Interactions (Avoid): - Incompatible preservatives: may cause precipitation or loss of viscosity. - Strong acids or bases: can degrade the polymer structure.

Moderate Interactions (Monitor Closely): - Other ophthalmic gels: may alter overall viscosity profile. - Contact lens solutions: could affect lens comfort or adherence. - Systemic anti‑inflammatory eye drops: may modify the ocular environment, requiring observation.